The US Food and Drug Administration (FDA) has formed an internal Nanotechnology Task Force to oversee regulations pertaining to the development of innovative, safe, and effective FDA-regulated products that use nanotechnology materials (which have components with dimensions at roughly 1 to 100 nanometers).
The task force will chair a public meeting in October (http://www.fda.gov/OHRMS/DOCKETS/98fr/06n-0107-nm00002.pdf) to help the FDA further its understanding of developments in nanotechnology materials; explore opportunities to foster innovation using nanotechnology materials to develop safe and effective drugs and devices, and to develop safe foods and cosmetics; and consider appropriate ways to communicate with the public about the use of nanotechnology materials in FDA-regulated products.
Hampton T. Nanotechnology Task Force. JAMA. 2006;296(12):1458. doi:10.1001/jama.296.12.1458-c
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: